Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Multicenter, Placebo-Controlled Clinical Trial of Colchicine to Reduce Coronary Artery Inflammation in People With HIV. COLCOHIV

NCT07704164 is registered in ClinicalTrials.gov with Instituto de Investigación Hospital Universitario La Paz as lead sponsor.

NCT NCT07704164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07704164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Multicenter, Placebo-Controlled Clinical Trial of Colchicine to Reduce Coronary Artery Inflammation in People With HIV. COLCOHIV
Lead sponsor
Instituto de Investigación Hospital Universitario La Paz
Phase
Phase 2
Overall status
Recruiting
Start date
June 30, 2026
Completion date
June 30, 2029
Enrollment
90 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), hiv infection